Largest biotech and pharma deals – 2018 recap & 2019 outlook 24 januari, 2019The year 2019 started out strong with the announcement of Bristol Myers Squibb acquisition of Celgene for about $74 billion. In size, this deal undoubtedly trumps the deals struck in 2018 but, importantly, sign... LÄS MER!
